Obesity genetics in mouse and human: back and forth, and back again

FT Yazdi, SM Clee, D Meyre - PeerJ, 2015 - peerj.com
Obesity is a major public health concern. This condition results from a constant and complex
interplay between predisposing genes and environmental stimuli. Current attempts to …

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14

H Wang, ZY Li, Y Liu, J Persson, I Beyer, T Möller… - Nature medicine, 2011 - nature.com
We have identified desmoglein-2 (DSG-2) as the primary high-affinity receptor used by
adenoviruses Ad3, Ad7, Ad11 and Ad14. These serotypes represent key human pathogens …

Developing strategies for detection of gene doping

A Baoutina, IE Alexander, JEJ Rasko… - The Journal of Gene …, 2008 - Wiley Online Library
It is feared that the use of gene transfer technology to enhance athletic performance, the
practice that has received the term 'gene doping', may soon become a real threat to the …

The aging of elite male athletes: age-related changes in performance and skeletal muscle structure and function

JA Faulkner, CS Davis, CL Mendias… - Clinical Journal of Sport …, 2008 - journals.lww.com
Objective: The paper addresses the degree to which the attainment of the status as an elite
athlete in different sports ameliorates the known age-related losses in skeletal muscle …

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

S Li, E Kimura, BM Fall, M Reyes, JC Angello… - Gene therapy, 2005 - nature.com
Gene therapy for Duchenne muscular dystrophy (DMD) will require sustained expression of
therapeutic dystrophins in striated muscles. Lentiviral vectors have a relatively large …

Potential use of gene transfer in athletic performance enhancement

A Baoutina, IE Alexander, JEJ Rasko, KR Emslie - Molecular therapy, 2007 - cell.com
After only a short history of three decades from concept to practice, gene therapy has
recently been shown to have potential to treat serious human diseases. Despite this …

Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression

E Kimura, S Li, P Gregorevic, BM Fall, JS Chamberlain - Molecular Therapy, 2010 - cell.com
To explore whether stable transduction of myogenic stem cells using lentiviral vectors could
be of benefit for treating dystrophic muscles, we generated vectors expressing a functional …

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

K Binley, Z Askham, S Iqball… - Blood, The Journal …, 2002 - ashpublications.org
Anemia is a common clinical problem, and there is much interest in its role in promoting left
ventricular hypertrophy through increasing cardiac workload. Normally, red blood cell …

Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer

J Seppen, R Van Der Rijt, N Looije, NP Van Til… - Molecular therapy, 2003 - cell.com
Bilirubin is glucuronidated by bilirubin UDP-glucuronyltransferase (UGT1A1) before biliary
excretion. Because bilirubin is toxic, patients with Crigler–Najjar type I (CN), who have no …

Lentiviral vectors

AML Lever - … , Applications and Regulations: From Laboratory to …, 1999 - Wiley Online Library
Lentiviruses are a subfamily of retroviruses infecting primate and non‐primate hosts. They
have multiple spliced RNA species and several small regulatory proteins that allow …